Quality Indicators of Supportive Care for Patients with Cancer Undergoing Treatment: a Systematic Review

Overview

Journal BMC Cancer

Publisher Biomed Central

Date 2025 Jan 20

PMID 39833732

Authors

Ayako Okuyama

Mai Kuwabara

Sadamoto Zenda

Affiliations

Soon will be listed here.

Abstract

Background: Patients need to be supported in combining treatment with daily life. However, measurement of supportive care indicators related to treatment-related side effects is under-reported. This review aimed to identify a list of quality indicators for managing cancer treatment-induced toxicities for adult patients with cancer.

Methods: A review was conducted on PubMed, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Database of Systematic Reviews, and Embase from September 26, 2013 to December 26, 2023. Published English articles that developed or analyzed quality indicators of managing cancer treatment-induced toxicities for adult patients with cancer were selected. The identified indicators were classified according to Donabedian's model for quality of care in healthcare.

Results: Forty-two indicators (4 structural, 27 process, and 11 outcome indicators) in 18 articles were identified. Eight articles (44.4%) were from North America, four (22.2%) from Europe, two (11.1%) from Oceania, two (11.1%) from Asia, and one (5.6%) from Africa; 64.3% of the indicators were process indicators based on guidelines. The prevalence of patient symptoms determined using a patient-reported outcome measure was proposed as an outcome indicator. In seven studies (38.9%), these indicators were selected by multidisciplinary experts. None of the studies involved patients or family members in the indicator selection process.

Conclusion: The quality of supportive care should be improved by measuring these indicators, considering the patient's needs for supportive care at each hospital such that patients can continue their lives while undergoing treatment.

References

Keating N, Cleveland J, Wright A, Brooks G, Meneades L, Riedel L . Evaluation of Reliability and Correlations of Quality Measures in Cancer Care. JAMA Netw Open. 2021; 4(3):e212474. PMC: 7985722. DOI: 10.1001/jamanetworkopen.2021.2474. View

Wani S, Wallace M, Cohen J, Pike I, Adler D, Kochman M . Quality indicators for EUS. Gastrointest Endosc. 2014; 81(1):67-80. DOI: 10.1016/j.gie.2014.07.054. View

Van Ryn M, Phelan S, Arora N, Haggstrom D, Jackson G, Zafar S . Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System. J Clin Oncol. 2014; 32(8):809-15. PMC: 3940539. DOI: 10.1200/JCO.2013.49.4302. View

De Roo M, Leemans K, Claessen S, Cohen J, Pasman H, Deliens L . Quality indicators for palliative care: update of a systematic review. J Pain Symptom Manage. 2013; 46(4):556-72. DOI: 10.1016/j.jpainsymman.2012.09.013. View

Bastemeijer C, Boosman H, van Ewijk H, Verweij L, Voogt L, Hazelzet J . Patient experiences: a systematic review of quality improvement interventions in a hospital setting. Patient Relat Outcome Meas. 2019; 10:157-169. PMC: 6535098. DOI: 10.2147/PROM.S201737. View

Bao H, Yang F, Wang X, Su S, Liu D, Fu R . Developing a set of quality indicators for breast cancer care in China. Int J Qual Health Care. 2015; 27(4):291-6. DOI: 10.1093/intqhc/mzv042. View

Dy S, Walling A, Mack J, Malin J, Pantoja P, Lorenz K . Evaluating the quality of supportive oncology using patient-reported data. J Oncol Pract. 2014; 10(4):e223-30. PMC: 5706118. DOI: 10.1200/JOP.2013.001237. View

Ryoo J, Malin J, Ordin D, Oishi S, Kim B, Asch S . Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol. 2014; 9(4):447-55. DOI: 10.1097/JTO.0000000000000108. View

Donnelly C, Or M, Toh J, Thevaraja M, Janssen A, Shaw T . Measurement that matters: A systematic review and modified Delphi of multidisciplinary colorectal cancer quality indicators. Asia Pac J Clin Oncol. 2023; 20(2):259-274. DOI: 10.1111/ajco.13917. View

10.

Guarneri V, Pronzato P, Bertetto O, Roila F, Amunni G, Bortolami A . Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy. JCO Oncol Pract. 2019; 16(2):e211-e220. PMC: 7025426. DOI: 10.1200/JOP.19.00466. View

11.

Thu Ma A, Barone J, Wallis A, Wu N, Garcia L, Estabrook A . Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg. 2008; 196(4):500-4. DOI: 10.1016/j.amjsurg.2008.06.027. View

12.

Boyle J, van der Meulen J, Kuryba A, Cowling T, Booth C, Fearnhead N . Measuring variation in the quality of systemic anti-cancer therapy delivery across hospitals: A national population-based evaluation. Eur J Cancer. 2022; 178:191-204. DOI: 10.1016/j.ejca.2022.10.017. View

13.

Khare S, Aprikian A, Black P, Blais N, Booth C, Brimo F . Quality indicators in the management of bladder cancer: A modified Delphi study. Urol Oncol. 2017; 35(6):328-334. DOI: 10.1016/j.urolonc.2016.12.003. View

14.

Jordan K, Aapro M, Kaasa S, Ripamonti C, Scotte F, Strasser F . European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol. 2017; 29(1):36-43. DOI: 10.1093/annonc/mdx757. View

15.

Brown N, Lui C, Robinson P, Boyle F . Supportive care needs and preferences of lung cancer patients: a semi-structured qualitative interview study. Support Care Cancer. 2014; 23(6):1533-9. DOI: 10.1007/s00520-014-2508-5. View

16.

Iwamoto M, Nakamura F, Higashi T . Monitoring and evaluating the quality of cancer care in Japan using administrative claims data. Cancer Sci. 2015; 107(1):68-75. PMC: 4724820. DOI: 10.1111/cas.12837. View

17.

Donabedian A . Evaluating the quality of medical care. 1966. Milbank Q. 2005; 83(4):691-729. PMC: 2690293. DOI: 10.1111/j.1468-0009.2005.00397.x. View

18.

Sundar S, Nordin A, Morrison J, Wood N, Ghaem-Maghami S, Nieto J . British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer. Cancers (Basel). 2023; 15(2). PMC: 9856668. DOI: 10.3390/cancers15020337. View

19.

Vanhauwaert D, Pinson H, Sweldens C, Du Four S, Van Eycken L, De Schutter H . Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey. J Neurooncol. 2022; 157(2):365-376. DOI: 10.1007/s11060-022-03971-3. View

20.

Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J . Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006; 6:35. PMC: 1559637. DOI: 10.1186/1471-2288-6-35. View